本分类收录的细胞产品与配套技术资料，支持按来源、物种与规格筛选。 共 293 个产品。
HighQC™ Human IPSC From B-Lymphocyte-Ceroid Lipofuscinosis to model CLN2-related neurodegeneration and support drug discovery for lysosomal disorders.
HighQC™ Human IPSC From B-Lymphocyte-Personal Genome Project is a human induced pluripotent stem cell line generated from B-lymphocytes isolated from the peripheral blood mononuclear cells (PBMCs) of a healthy donor participating in the Personal Genome Project. The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with a high nucleus-to-cytoplasm ratio. These cells possess the fundamental capacity for trilineage differentiation into cell types of the ectoderm, mesoderm, and endoderm germ layers. They express the core pluripotency marker SSEA-4 and retain B-lymphocyte-derived traits and reflect in vivo immune system physiology. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
HighQC™ Human IPSC From B-Lymphocyte (Facioscapulohumeral Muscular Dystrophy 1), HighQC™ hiPSC FSHD1, hiPSC-FSHD1, HighQC™ Human Induced Pluripotent Stem Cells From B-Lymphocyte-Facioscapulohumeral Muscular Dystrophy Type 1
Use HighQC™ Human IPSC From Cord Blood Cells CD34+ for pluripotent stem cell research, differentiation, and disease modeling in hematopoietic systems.
Cell Type iPSC Primary Tissue Corneal epithelial cells Reprogramming Method Episomal Plasmid.
Leverage HighQC™ Human IPSC from Corneal Epithelial Cells-Diabetes, ideal for studying diabetes and reprogramming research using episomal plasmids.
HighQC™ Human IPSC from fibroblasts enables stem cell research, regenerative medicine, and modeling genetic diseases using pluripotent stem cells.
HighQC™ Human IPSC From Fibroblast (Niemann-Pick Disease Type A) supports sphingolipid metabolism and SMPD1-related lysosomal storage disorder modeling.
HighQC™ Human IPSC From Fibroblast-Alzheimer Disease is a disease-specific human induced pluripotent stem cell line derived from dermal fibroblasts of a donor diagnosed with Alzheimer's Disease (AD). The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with a high nucleus-to-cytoplasm ratio. They retain the fundamental capacity to differentiate into cell types representing all three germ layers—ectoderm, mesoderm, and endoderm — under appropriate directed differentiation protocols. These cells express the key pluripotency-associated marker SSEA-4. They maintain AD-related neuronal physiology and reflect neural tissue function. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
HighQC™ Human iPSC From Fibroblast-Amyotrophic Lateral Sclerosis provides high-quality patient-derived iPSCs to support neurodegenerative research.
HighQC™ Human IPSC From Fibroblast-Apparently Healthy Individual is a human induced pluripotent stem cell line derived from dermal fibroblasts of a healthy donor. These healthy individual induced pluripotent stem cells exhibit adherent growth and retain the fundamental capacity to differentiate into cell types representing all three germ layers (ectoderm, mesoderm, and endoderm) under defined conditions. They maintain normal cellular physiology and reflect in vivo physiological functions. These iPSCs (induced pluripotent stem cells) express the core pluripotency marker SSEA-4. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
HighQC™ Human IPSC From Fibroblast-Charcot-Marie-Tooth Syndrome offers a patient-specific model for disease mechanisms, drug discovery and therapy testing.
HighQC™ Human IPSC From Fibroblast-Choroideremia is a disease-specific human induced pluripotent stem cell line derived from dermal fibroblasts of a donor diagnosed with Choroideremia, an X-linked recessive chorioretinal dystrophy caused by mutations in the CHM gene. The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with a high nucleus-to-cytoplasm ratio. They maintain pluripotency and reflect CHM-related retinal traits. These cells retain the fundamental capacity for trilineage differentiation into cell types of the ectoderm, mesoderm, and endoderm germ layers. Core pluripotency marker SSEA-4 is expressed. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
Employ HighQC™ Human IPSC From Fibroblast-Congenital Disorder Of Deglycosylation for rare genetic disease modeling, drug testing, and molecular studies.
HighQC™ Human iPSC From Fibroblast–Juvenile-Onset Diabetes provides an integration-free iPSC model for autoimmune diabetes research and drug. in vitro.
HighQC™ Human IPSC From Fibroblast-Dystrophia Myotonica 1 is a disease-specific induced pluripotent stem cell line generated from dermal fibroblasts of a donor diagnosed with Myotonic Dystrophy Type 1 (DM1). The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth and retain the fundamental capacity for trilineage differentiation into ectoderm, mesoderm, and endoderm derivatives. These iPSCs express the core pluripotency marker SSEA-4. They retain DM1-related cellular features and reflect neuromuscular physiology in vivo. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
HighQC™ Human IPSC From Fibroblast-Epidermolysis Bullosa: Dystrophic, Junctional, Or Simplex Types, ideal for disease modeling and therapeutic research.
HighQC™ Human IPSC From Fibroblast-Familial Alzheimer’s Disease models Alzheimer’s pathology and supports drug development using disease-relevant iPSCs.
HighQC™ Human IPSC From Fibroblast-Huntington Disease, HighQC™ hiPSC HD, hiPSC-HD, HighQC™ Human Induced Pluripotent Stem Cells From Fibroblast-Huntington Disease
Leverage HighQC™ Human IPSC From Fibroblast-Huntington’s Disease Like to model neurodegenerative conditions and test therapeutic interventions.
HighQC™ Human IPSC From Fibroblast-Hutchinson-Gilford Progeria Syndrome, HighQC™ hiPSC HGPS, hiPSC-HGPS, HighQC™ Human Induced Pluripotent Stem Cells From Fibroblast-Hutchinson-Gilford Progeria Syndrome
HighQC™ Human IPSCs From Fibroblasts-Kearns-Sayre Syndrome are a disease-affected induced pluripotent stem cell line generated from patient-derived dermal fibroblasts obtained via skin biopsy, carrying Kearns–Sayre syndrome–associated mitochondrial abnormalities, a heritable mitochondrial disorder. These cells exhibit classical human iPSC morphology, including compact colonies with well-defined borders, a high nucleus-to-cytoplasm ratio, and prominent nucleoli. These iPSCs exhibit pluripotency, with the ability to differentiate into all three germ layers under defined conditions, and express the pluripotency marker SSEA-4. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
HighQC™ Human IPSC From Fibroblast-Krabbe Disease, HighQC™ hiPSC Krabbe, hiPSC-Krabbe, HighQC™ Human Induced Pluripotent Stem Cells From Fibroblast-Krabbe Disease
HighQC™ Human IPSC From Fibroblast-Lesch-Nyhan Syndrome carries HPRT1 mutation, modeling metabolic disorder pathology for drug and gene therapy studies.
共 293 个产品 ｜ 第 4 / 13 页
